AlzeCure Pharma: AlzeCure is Moving Towards Phase IIa Clinic

STOCKHOLM, SWEDEN / ACCESSWIRE / February 8, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule

Related Keywords

Sweden , United States , Stockholm , Swedish , Alzecure Pharma , Johan Sandin , Drug Administration , Nobel Prize , Fast Track Designation , Nasdaq First North Premier Growth Market , Alzecure , Dharma , Moving , Cowards , Hase , Linical , Trial , Cd440 , Ased , Guiding , Response , Rom ,